AV网站国产不卡|a阿V天堂亚洲阿∨天堂在线|a在线视频播放免费视|yy717午夜福利

  • <legend id="zd4np"><u id="zd4np"><blockquote id="zd4np"></blockquote></u></legend>

      <s id="zd4np"></s>
      <sup id="zd4np"></sup>

    1. <sup id="zd4np"><dl id="zd4np"></dl></sup>

      好醫(yī)匯

      手機(jī)版
      手機(jī)版
      用戶中心
      array(25) {
        ["id"]=>
        string(5) "79083"
        ["name"]=>
        string(9) "林東昕"
        ["avatar"]=>
        string(71) "https://img.39yst.com/uploads/117/e5b64ccac9799e100ea7497b183bf714.jpeg"
        ["status"]=>
        string(1) "0"
        ["rank_type"]=>
        string(2) "41"
        ["duodian_main_id"]=>
        string(1) "0"
        ["miaopai"]=>
        string(0) ""
        ["graphic_consult"]=>
        string(1) "0"
        ["position"]=>
        string(9) "研究員"
        ["introduction"]=>
        string(34308) "中國工程院院士、研究員(教授)、博士生導(dǎo)師?,F(xiàn)任中國醫(yī)學(xué)科學(xué)院北京協(xié)和醫(yī)學(xué)院腫瘤醫(yī)院病因及癌變研究室主任,癌發(fā)生及預(yù)防分子機(jī)理北京市重點(diǎn)實(shí)驗(yàn)室主任;北京協(xié)和醫(yī)學(xué)院學(xué)術(shù)委員會委員,北京大學(xué)醫(yī)學(xué)部學(xué)術(shù)委員會委員,分子腫瘤學(xué)國家重點(diǎn)實(shí)驗(yàn)室學(xué)術(shù)委員。 1986  年北京醫(yī)科大學(xué)研究生畢業(yè),醫(yī)學(xué)碩士學(xué)位。 1988 年 8 月至 1990 年 6 月在法國國家科學(xué)研究中心腫瘤研究所和世界衛(wèi)生組織國際癌癥研究中心 (  IARC  ) , 1990 年 7 月至 1994 年 8 月在美國國家毒理學(xué)研究中心從事腫瘤基礎(chǔ)研究。 1995 到腫瘤醫(yī)院腫瘤研究所工作。國家杰出青年科學(xué)基金獲得者 ( 1998年 );衛(wèi)生部有突出貢獻(xiàn)中青年專家(2003 - 2004年度 ) ;國務(wù)院頒發(fā)政府特殊津貼專家 (2001年) 。2013年當(dāng)選為中國工程院院士。
      
      學(xué)術(shù)兼職:中國抗癌協(xié)會理事、腫瘤病因?qū)I(yè)委員會主任委員,中國吸煙與健康協(xié)會理事;國際專業(yè)期刊 Int J Cancer、PharmacogenetGenomics、Biomed Environ Sci,國內(nèi)專業(yè)期刊《中華腫瘤雜志》和《癌癥》等編委。研究領(lǐng)域?yàn)槌R娔[瘤發(fā)生發(fā)展及其遺傳易感性的分子機(jī)制;腫瘤分子流行病學(xué); 個體化醫(yī)學(xué)。曾承擔(dān)和正在承擔(dān)國家 " 973 " 重大基礎(chǔ)研究規(guī)劃、 國家" 863 "高技術(shù)項(xiàng)目、 國家自然科學(xué)基金重大項(xiàng)目、 國家自然科學(xué)基金重點(diǎn)項(xiàng)目、國家杰出青年科學(xué)基金項(xiàng)目、國家醫(yī)學(xué)科技攻關(guān)項(xiàng)目等重要的科研項(xiàng)目。
      
      主要學(xué)術(shù)貢獻(xiàn):揭示并闡明我國食管癌、 胰腺癌、 肺癌等腫瘤的易感基因及基因 - 環(huán)境交互作用、 遺傳變異對腫瘤放化療療效及預(yù)后的影響。 至 2014 年已發(fā)表科學(xué)論文 210 余篇, 其中13篇發(fā)表在遺傳學(xué)領(lǐng)域頂級期刊Nature Genetics。論文累計SCI影響因子1100 多分,被引用 9500 多次。參與主編或編寫《腫瘤遺傳學(xué)》、《腫瘤學(xué)》、《臨床腫瘤學(xué)》等專著。研究成果獲2006年國家自然科學(xué)獎二等獎、2008年國家科技進(jìn)步獎二等獎和2011年教育部自然科學(xué)獎一等獎等。發(fā)表在Nature Genetics的文章( Sun et al, Nat Genet 2007; 39: 605 - 613 )被評為 2007 年度中國基礎(chǔ)研究十大新聞。已培養(yǎng)腫瘤學(xué)畢業(yè)博士研究生 20 余名,其中 4 名博士研究生論文被評為 2006 、 2008 、 2009 年和 2013 年全國優(yōu)秀博士學(xué)位論文。
      
      
      
      發(fā)表論文目錄(* 通訊作者或第一作者)
      
      1.Chu M, Zhang R, Zhao Y, Wu C, Guo H, Zhou B, Lv J, Shi Y, Dai J, Jin G, Ma H, Dong J, Wei Y, Wang C, Gong J, Sun C, Zhu M, Qiu Y, Wu T, Hu Z, Lin D, Shen H, Chen F*.A genome-wide gene-gene interaction analysis identifies an epistatic gene pair for lung cancer susceptibility in Han Chinese. Carcinogenesis 2013 Dec 9 [Epub ahead of print]
      
      
      
      2.Wu C, Kraft P, Stolzenberg-Solomon R, Steplowski E, Brotzman M, Xu M, Mudgal P, Amundadottir L, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, Kooperberg C, Petersen GM, Zheng W, Albanes D, Boutron-Ruault M-C, Buring JE, Canzian F, Cao G, Duell EJ, Elena JL, Gaziano JM…Fuchs CS, Lin D*, Wolpin BM*. Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Gut 2014;63:152–160.
      
      
      
      3.He M*, Wu C*, Xu J*, Guo H*, Yang H, Zhang X, Sun J, Yu D, Zhou L, Peng T, He Y, Gao Y, Yuan J, Deng Q, Dai X, Tan A, Feng Y, Zhang H, Min X, Yang X, Zhu J, Zhai K, Chang J, Qin X, Tan W, Hu Y, Lang M, Tao S, Li Y, Li Y, Feng J, Li D, Kim ST, Zhang S, Zhang H, Zheng SL, Gui L, Wang Y, Wei S, Wang F, Fang W, Liang Y, Zhai Y, Chen W, Miao X, Zhou G, Hu FB, Lin D, Mo Z, Wu T*. A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigenα fetoproteintheir associations with cancer risk. Gut 2014;63:143–151.
      
      
      
      4.Li J, Gui L, Wu C, He Y, Zhou L, Guo H, Yuan J, Yang B, Dai X, Deng Q, Huang S, Guan L, Hu D, Deng S, Wang T, Zhu J, Min X, Lang M, Li D, Yang H, Hu FB, Lin D, Wu T, He M*. Genome-wide association study on serum alkaline phosphatase levels in a Chinese population. BMC Genomics 2013; 14:684.
      
      
      
      5.Shi Y, Li L, Hu Z, Li S, Wang S, Liu J, Wu C, He L, Zhou J, Li Z, Hu T, Chen Y, Jia Y, Wang S, Wu L, Cheng X, Yang Z, Yang R, Li X, Huang K, Zhang Q, Zhou H, Tang F, Chen Z, Shen J, Jiang J, Ding H, Xing H, Zhang S, Qu P, Song X, Lin Z, Deng D, Xi L, Lv W, Han X, Tao G, Yan L, Han Z, Li Z, Miao X, Pan S, Shen Y, Wang H, Liu D, Gong E, Li Z, Zhou L, Luan X, Wang C, Song Q, Wu S, Xu H, Shen J, Qiang F, Ma G, Liu L, Chen X, Liu J, Wu J, Shen Y, Wen Y, Chu M, Yu J, Hu X, Fan Y, He H, Jiang Y, Lei Z, Liu C, Chen J, Zhang Y, Yi C, Chen S, Li W, Wang D, Wang Z, Di W, Shen K, Lin D, Shen H, Feng Y, Xie X, Ma D*. A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q1217q12. Nat Genet 2013; 45:918–922.
      
      
      
      6. Du J, Xu Y, Dai J, Ren C, Zhu C, Dai N, Ma H, Shi Y, Hu Z, Lin D, Shen H, Jin G*. Genetic variants at 5p15 are associated with riskearly-onset of gastric cancer in Chinese populations. Carcinogenesis 2013; 34:2539–2542.
      
      
      
      7.Tan DE, Foo JN, Bei JX, Chang J, Peng R, Zheng X, Wei L, Huang Y, Lim WY, Li J, Cui Q, Chew SH, Ebstein RP, Kuperan P, Lim ST, Tao M, Tan SH, Wong A, Wong GC, Tan SY, Ng SB, Zeng Y, Khor CC, Lin D*, Seow AL*, Jia W*, Liu J*. Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population. Nat Genet 2013; 45:804–807.
      
      
      
      8.Zhang X, Wei J, Zhou L, Zhou C, Shi J, Yuan Q, Yang M*, Lin D. A functional BRCA1 coding sequence genetic variant contributes to risk of esophageal squamous cell carcinoma. Carcinogenesis 2013; 34:2309–2313.
      
      
      
      9. Wu C, Li D, Jia W, Hu Z, Zhou Y, Yu D, Tong T, Wang M, Lin D, Qiao Y, Zjou Y, Chang J, Zhai K, Wang M, Wei L, Tan W, Shen H, Zeng Y, Lin D*. Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma patients. Nat Genet 2013; 45:632–638.
      
      
      
      10.Deng Q, Guo H, Dai J, Yang L, Wu C, Wang Q, Hu Z, Yang M, Liu L, Yu D, Hu D, Hong X, Qiu F, Yang H, Wang T, Tan W, Chu M, Feng J, Teng K, Gong J, Sun C, Hu X, Zhang K, Lu J, Lin D, Shen H, Wu T*. Imputation-based association analyses identify new lung cancer susceptibility variants in CDK6SH3RF1their interactions with smoking in Chinese populations. Carcinogenesis 2013; 34:2010–2016.
      
      
      
      11.Chang J, Huang Y, Wei L, Ma B, Miao X, Li Y, Hu Z, Yu D, Jia W, Liu Y, Tan W, He Z, Ke Y, Wu T, Shen H, Zeng Y, Wu C*, Lin D*. Risk prediction of esophageal squamous-cell carcinoma with common genetic variantslife-style factors in Chinese population. Carcinogenesis 2013; 34:1782–1786.
      
      
      
      12.Qiao Y, Zhou Y, Wu C, Zhai K, Han X, Chen J, Tian X, Chang J, Lu Z, Zhang B, Yu D, Yao J, Shi Y*, Tan W*, Lin D. Risk of genome-wide association study-identified genetic variants for NHL in a Chinese population.Carcinogenesis 2013; 34:1516–1519.
      
      
      
      13.Wu C, Chang J, Ma B, Miao X, Zhou Y, Liu Y, Li Y, Wu T, Hu Z, Shen H, Jia W, Zeng Y, Lin D*, Kraft P*. The case-only test of gene-environment interaction is not uniformly powerful: An empirical example. Genet Epidemiol 2013; 37:402–407.
      
      
      
      14.Zhang R, Zhao Y, Chu M, Wu C, Jin G, Dai J, Wang C, Hu L, Gou J, Qian C, Bai J, Wu T, Hu Z, Lin D, Shen H, Chen F*. Pathway analysis for genome-wide association study of lung cancer in Han Chinese population.PLoS One 2013; 8:e57763.
      
      
      
      15.Ma F, Zhang P, Lin D, Yu D, Yuan P, Wang J, Fan Y, Xu B*. There Is No association between microRNA gene polymorphismsrisk of triple negative breast cancer in a Chinese Han population. PLoS One 2013; 8:e60195.
      
      
      
      16.Dai X, Wu C, He Y, Gui L, Zhou L, Guo H, Yuan J, Yang B, Li J, Deng Q, Huang S, Guan L, Hu D, Zhu J, Min X, Lang M, Li D, Yang H, Hu FB, Lin D, Wu T, He M*. A genome-wide association study for serum bilirubin levelsgene-environment interaction in a Chinese population. Genet Epidemiol 2013; 37:293–300.
      
      
      
      17.Dong J, Jin G, Wu C, Guo H, Zhou B, Lv J, Lu D, Shi Y, Shu Y, Xu L, Chu M, Wang C, Zhang R, Dai J, Jiang Y, Yu D, Ma H, Zhao X, Yin Z, Yang L, Li Z, Deng Q, Cao S, Qin Z, Gong J, Sun C, Wang J, Wu W, Zhou G, Chen H, Guan P, Chen Y, Liu X, Liu L, Xu P, Han B, Bai C, Zhao Y, Zhang H, Yan Y, Liu J, Amos CI, Chen F, Tan W, Jin L, Wu T, Hu Z*, Lin D*, Shen H*. Genome-wide association study identifies a novel susceptibility locus at 12q23.1 for lung squamous cell carcinoma in Han Chinese. PLoS Genet 2013; 9:e1003190.
      
      
      
      18.Huang L, Wu C, Yu D, Wang C, Che X, Miao X, Zhai K, Chang J, Jiang G, Yang X, Cao G, Hu Z, Zhou Y, Zuo C, Wang C, Zhang X, Zhou Y, Yu X, Dai W, Li Z, Shen H, Liu L, Chen Y, Zhang S, Wang X, Liu Y, Sun M, Cao W, Gao J, Ma Y, Zheng X, Cheung ST, Jia Y, Tan W, Wu T, Lin D*. Identification of common variants in BRCA2MAP2K4 for susceptibility to sporadic pancreatic cancer. Carcinogenesis 2013; 34:1001–1005.
      
      
      
      19.Zhang T, Cai J, Chang J, Yu D, Wu C, Yan T, Zhai K, Bi X, Zhao H, Xu J, Tan W, Qu C, Lin D*. Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infectionhepatocellular carcinoma. Hum Mol Genet 2013; 22:1262–1269.
      
      
      
      20.Liu L, Wu J, Zhong R, Wu C, Zou L, Yang B, Chen W, Zhu B, Duan S, Yu D, Tan W, Nie S, Lin D*, Miao X*.Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer.Mol Carcinog 2013; 52:923–931.
      
      
      
      21.Jiang DK*, Sun J*, Cao G*, Liu Y*, Lin D*, Gao YZ, Ren WH, Long XD, Zhang H, Ma XP, Wang Z, Jiang W, Chen TY, Gao Y, Sun LD, Long JR, Huang HX, Wang D, Yu H, Zhang P, Tang LS, Peng B, Cai H, Liu TT, Zhou P, Liu F, Lin X, Tao S, Wan B, Sai-Yin HX, Qin LX, Yin J, Liu L, Wu C, Pei Y, Zhou YF, Zhai Y, Lu PX, Tan A, Zuo XB, Fan J, Chang J, Gu X, Wang NJ, Li Y, Liu YK, Zhai K, Zhang H, Hu Z, Liu J, Yi Q, Xiang Y, Shi R, Ding Q, Zheng W, Shu XO, Mo Z, Shugart YY, Zhang XJ, Zhou G, Shen H, Zheng SL, Xu J*, Yu L*. Genetic variants in STAT4HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet 2012; 45:72–75.
      
      
      
      22.Wu C, Kraft P, Zhai K, Chang J, Zhao W, Li Y, Hu Z, He Z, Jia W, Abnet CC, Liang L, Hu N, Miao X, Zhou Y, Liu Z, Zhan Q, Liu Y, Qiao Y, Zhou Y, Jin G, Guo C, Lu C, Yang H, Fu J, Yu D, Freedman ND, Ding T, Tan W, Goldstein AM, Wu T, Shen H, Ke Y, Zeng Y, Chanock SJ, Taylor PR, Lin D*. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility locigene-environment interactions.Nat Genet 2012; 44:1090–1097.
      
      
      
      23.Lan Q, Hsiung CA, Matsuo K, …, Wu T*, Wu Y*, Yang P-C*, Zhou B*, Shin M-H*, Fraumeni Jr F*, Lin D*, Chanock SJ*, Rothman N*. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.Nat Genet 2012; 44:1330–1335 (*Jointly directed this study).
      
      
      
      24.Jin G, Ma H, Wu C, Dai J, Zhang R, Shi Y, Lu J, Miao X, Wang M, Zhou Y, Chen J, Li H, Pan S, Chu M, Yu D, Jiang Y, Dong J, Hu L, Chen Y, Xu L, Shu Y, Pan S, Tan W, Zhou B, Lu D, Wu T, Zhang Z, Chen F, Wang X, Hu Z*, Lin D*, Shen H. Genetic variants at 6p21.17p15.3 are associated with risk of multiple cancers: evidence from three genome-wide association studies on different cancers in Han Chinese populations. Am J Hum Genet 2012; 91:928–934.
      
      
      
      25.Hu L, Wu C, Zhao X, Heist RS, Su L, Zhao Y, Han B, Cao S, Chu M, Dai J, Dong J, Shu Y, Xu L, Chen Y, Wang Y, Lu F, Jiang Y, Yu D, Chen H, Tan W, Ma H, Chen J, Jin G, Wu T, Lu D, Christiani DC, Lin D, Hu Z, Shen H*. Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy. Clin Cancer Res 2012; 18:5507–5514.
      
      
      
      26.Li S, Qian J, Yang Y, Zhao W, Dai J, Bei JX, Foo JN, McLaren PJ, Li Z, Yang J, Shen F, Liu L, Yang J, Li S, Pan S, Wang Y, Li W, Zhai X, Zhou B, Shi L, Chen X, Chu M, Yan Y, Wang J, Cheng S, Shen J, Jia W, Liu J, Yang J, Wen Z, Li A, Zhang Y, Zhang G, Luo X, Qin H, Chen M, Wang H, Jin L, Lin D, Shen H, He L, de Bakker PI, Wang H, Zeng YX, Wu M, Hu Z, Shi Y, Liu J, Zhou W*. GWAS identifies novel susceptibility loci on 6p21.3221q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet 2012; 8(7):e1002791.
      
      
      
      27.Dong J#, Hu Z#, Wu C#, Guo H, Zhou B, Lv J, Lu D, Chen K, Shi Y, Chu M, Wang C, Zhang R, Dai J, Jiang Y, Cao S, Qin Z, Yu D, Ma H, Jin G, Gong J, Sun C, Zhao X, Yin Z, Yang L, Li Z, Deng Q, Wang J, Wu W, Zheng H, Zhou G, Chen H, Guan P, Peng Z, Chen Y, Shu Y, Xu L, Liu X, Liu L, Xu P, Han B, Bai C, Zhao Y, Zhang H, Yan Y, Amos CI, Chen F, Tan W, Jin L, Wu T, Lin D, Shen H*. Association analyses identify multiple new lung cancer susceptibility locitheir interactions with smoking in the Chinese population. Nat Genet 2012; 44:895–899.
      
      
      
      28.Chen LS, Saccone NL, Culverhouse RC, Bracci PM, Chen CH, Dueker N, Han Y, Huang H, Jin G, Kohno T, Ma JZ, Przybeck TR, Sanders AR, Smith JA, Sung YJ, Wenzlaff AS, Wu C, Yoon D, Chen YT, Cheng YC, Cho YS, David SP, Duan J, Eaton CB, Furberg H, Goate AM, Gu D, Hansen HM, Hartz S, Hu Z, Kim YJ, Kittner SJ, Levinson DF, Mosley TH, Payne TJ, Rao DC, Rice JP, Rice TK, Schwantes-An TH, Shete SS, Shi J, Spitz MR, Sun YV, Tsai FJ, Wang JC, Wrensch MR, Xian H, Gejman PV, He J, Hunt SC,Kardia SL, Li MD, Lin D, Mitchell BD, Park T, Schwartz AG, Shen H, Wiencke JK, Wu JY, Yokota J, Amos CI, Bierut LJ*. Smokinggenetic risk variation across populations of European, Asian,African American ancestry--a meta-analysis of chromosome 15q25. Genet Epidemiol 2012; 36:340–351.
      
      
      
      29.Dey S, Maiti AK, Hegde ML, Hegde PM, Boldogh I, Sarkar PS, Abdel-Rahman SZ, Sarker AH, Hang B, Xie J, Tomkinson AE, Zhou M, Shen B, Wang G, Wu C, Yu D, Lin D, Cardenas V, Hazra TK*. Increased risk of lung cancer associated with a functionally impaired polymorphic variant of the human DNA glycosylase NEIL2. DNA Repair (Amst) 2012; 11:570–578.
      
      
      
      30.Hosgood HD 3rd, Wang WC, Hong YC, Wang JC, Chen K, Chang IS, Chen CJ, Lu D, Yin Z, Wu C, Zheng W, Qian B, Park JY, Kim YH, Chatterjee N, Chen Y, Chang GC, Hsiao CF, Yeager M, Tsai YH, Wei H, Kim YT, Wu W, Zhao Z, Chow WH, Zhu X, Lo YL, Sung SW, Chen KY, Yuenger J, Kim JH, Huang L, Chen YH, Gao YT, Kim JH, Huang MS, Jung TH, Caporaso N, Zhao X, Huan Z, Yu D, Kim CH, Su WC, Shu XO, Kim IS, Bassig B, Chen YM, Cha SI, Tan W, Chen H, Yang TY, Sung JS, Wang CL, Li X, Park KH, Yu CJ, Ryu JS, Xiang Y, Hutchinson A, Kim JS, Cai Q, Landi MT, Lee KM, Hung JY, Park JY, Tucker M, Lin CC, Ren Y, Perng RP, Chen CY, Jin L, Chen KC, Li YJ, Chiu YF, Tsai FY, Yang PC, Fraumeni JF Jr, Seow A, Lin D, Zhou B, Chanock S, Hsiung CA, Rothman N, Lan Q*. Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia.Hum Genet 2012; 131:1197–1203.
      
      
      
      31.Zhai K , Tian X, Wu C, Lu N, Chang J, Huang L, Zhang T, Zhou Y, Qiao Y, Yu D, Tan W, Chen J*, Lin D*. Cytokine BAFF gene variation is associated with survival of patients with T-cell lymphoma. Clin Cancer Res 2012; 18:2250–2256.
      
      
      
      32.Wu C, Miao X, Huang L, Che C, Jiang G, Yu D, Yang X, Cao G, Hu Z, Zhou Y, Zuo C, Wang C, Zhang X, Zhou Y, Yu X, Dai W, Li Z, Shen H, Liu L, Chen Y, Zhang S, Wang X, Zhai K, Chang J, Liu Y, Sun M, Cao W, Gao J, Ma Y, Zheng X, Cheung ST, Jia Y, Xu J, Tan W, Zhao P, Wu T, Wang C*, Lin D*. Genome-wide association study identif five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet 2012; 44:62–66.
      
      
      
      33.Huang L, Yu D, Wu C, Zhai K, Jiang G, Cao G, Wang C, Liu Y, Sun M, Li Z, Tan W, Lin D*. Copy number variation at 6q13 functions as a long-range regulatoris associated with pancreatic cancer risk. Carcinogenesis 2012; 33:94–100.
      
      
      
      34.Jiang Y, Wang W, Wang J, Lu Y, Chen Y, Jin L, Lin D, He F, Wang H*. Functional regulatory variants of MCL1 contribute to enhanced promoter activityreduced risk of lung cancer in nonsmokers: Implications for context-dependent phenotype of an antiapoptoticantiproliferative gene in solid tumor. Cancer 2011; 118:2085–2095.
      
      
      
      35.Guo H, Deng Q, Wu C, Hu L, Wei S, Xu P, Kuang D, Liu L, Hu Z, Miao X, Shen H, Lin D, Wu T*. Variations in HSPA1B at 6p21.3 are associated with lung cancer riskprognosis in Chinese populations.Cancer Res 2011; 71:7576–7586.
      
      
      
      36.Shi Y*, Hu Z, Wu C, Dai J, Li H, Dong J, Wang M, Miao X, Zhou Y, Lu F, Hu L, Jiang Y, Li Z, Chu M, Ma H, Chen J, Jin G, Tan W, Wu T, Zhang Z, Lin D*, Shen H*. A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.315p13.1. Nat Genet 2011; 43:1215–1218.
      
      
      
      37.Liu L, Wu J, Wu C, Wang Y, Zhong R, Zhang X, Tan W, Nie S, Miao X, Lin D*. A functional polymorphism (–1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with developmentprogression of lung cancer. Cancer 2011; 117:5172–5181.
      
      
      
      38.Liu L, Wu C, Wang Y, Zhong R, Duan S, Wei S, Lin S, Zhang X, Tan W, Yu D, Nie S, Miao X, Lin D*. Combined effect of genetic polymorphisms in P53, P73,MDM2 on non-small cell lung cancer survival. J Thorac Oncol 2011; 6:1793–1800.
      
      
      
      39.Hu Z, Wu C, Shi Y, Guo H, Zhao X, Yin Z, Yang L, Dai J, Hu L, Tan W, Li Z, Deng Q, Wang J, Wu W, Jin G, Jiang Y, Yu D, Zhou G, Chen H, Guan P, Chen Y, Shu Y, Xu L, Liu X, Liu L, Xu P, Han B, Bai C, Zhao Y, Zhang H, Yan Y, Ma H, Chen J, Chu M, Lu F, Zhang Z, Chen F, Wang X, Jin L, Lu J, Zhou B, Lu D, Wu T, Lin D, Shen H*. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.1222q12.2 in Han Chinese.Nat Genet 2011; 43:792–796.
      
      
      
      40.Xiong F, Wu C, Chang J, Yu D, Xu B, Yuan P, Zhai K, Xu J, Tan W, Lin D*. Genetic variation in MiRNA-1827 binding site of MYCL1susceptibility to small-cell lung cancer. Cancer Res 2011; 71:5175–5181.
      
      
      
      41.Wu C, He Z, Hu Z, Jia W, Wang F, Liu Z, Zhan Q, Liu Y, Yu D, Liu Z, Shen Y, Zhai K, Chang J, Qiao Y, Guo C, Jin G, Fu J, Miao X, Tan W, Wu T, Ke Y, Shen H, Zeng Y, Lin D*. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet 2011; 43:679–684.
      
      
      
      42.Liu L, Yuan P, Wu C, Zhang X, Wang F, Guo H, Zhong R, Xu Y, Wu J, Yu D, Wu T, Zhang X, Nie S*, Miao X*, Lin D. Assessment of XPD Lys751GlnXRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer 2011; 73:110–115.
      
      
      
      43.Yang M, Zhang L, Bi N, Ji W, Tan W, Zhao J, Yu D, Wu C, Wang L, Lin D*. Association of P53ATM polymorphisms with risk of radiation-induced pneumonitis in lung cancer patient treated with radiotherapy.Int J Radiat Oncol Biol Phys 2011; 79:1402–1407.
      
      
      
      44.Knappskog S, Bj?rnslett M, Myklebust LM, Huijts PE, Vreeswijk MP, Edvardsen H, Guo Y, Zhang X, Yang M, Ylisaukko-Oja SK, Alhopuro P, Arola J, Tollenaar RA, van Asperen CJ, Seynaeve C, Staalesen V, Chrisanthar R, L?kkevik E, Salvesen HB, Evans DG, Newman WG, Lin D, Aaltonen LA, B?rresen-Dale AL, Tell GS, Stoltenberg C, Romundstad P, Hveem K, Lillehaug JR, Vatten L, Devilee P, D?rum A, L?nning PE. The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor bindingreduces risk for breastovarian cancer in Caucasians.Cancer Cell 2011; 19:273–282.
      
      
      
      45.Liu L, Wu C, Wang Y, Zhong R, Wang F, Zhang X, Duan S, Lou J, Yu D, Tan W, Yuan J, Wu T, Nie S*, Miao X*, Lin D*. Association of candidate genetic variations with gastric cardia adenocarcinoma in Chinese population: a multiple-interaction analysis. Carcinogenesis 2011; 32:336–342.
      
      
      
      46.Zhang B, Sun T, Zhang B, Zheng S, Lu N, Xu B, Wang X, Cheng G, Yu D, Lin D*. Polymorphisms of GSTP1 is associated with differences of chemotherapy responsetoxicity in breast cancer. Chinese Med J 2011; 124:199–204.
      
      
      
      47.Xu J, Wu, C Wu, Che X, Wang Li, Yu D, Zhang T, Huang L, Li H, Tan W, Wang C*, Lin D*. Circulating microRNAs, miR-21, miR-122miR-223, in patients with hepatocellular carcinomachronic hepatitis.Mol Carcinogen 2011; 50:136–142.
      
      
      
      48.Chen X, Li H, Qiao Y, Yu D, Guo H, Tan W*, Lin D. Association of CD28 gene polymorphism with cervical cancer risk in a Chinese population. Int J Immunogenet 2011; 38:51–54.
      
      
      
      49.Cao Y, Miao X, Huang M, Deng L, Lin D, Zeng Y, Shao J*. Polymorphisms of death pathway genes FASFASLrisk of nasopharyngeal carcinoma.Mol Carcinogen 2010; 49:944–950.
      
      
      
      50.Cao Y, Miao X, Huang M, Xiong F, Deng L, Liang X, Lin D, Zeng Y, Shao J*. Polymorphisms of methylenetetrahydrofolate reductase are associated with a high risk of nasopharyngeal carcinoma in a smoking population from southern China. Mol Carcinogen2010; 49:928–934.
      
      
      
      51.Liu L, Yuan P, Liu L, Wu C, Zhang X, Guo H, Zhong R, Xu Y, Wu J, Duan S, Rui R, Wu T, Nie S, Miao X*, Lin D. A functional -77T>C polymorphism in XRCC1 is associated with risk of breast cancer. Breast Cancer Res Treat 2010; 125:479–487.
      
      
      
      52.Yuan P, Liu L, Wu C, Zhong R, Yu D, Wu J, Xu Y, Nie S, Miao X, Xu B, Lin D*. No association between 1 XRCC1 polymorphismssurvival in non-small-cell lung cancer patients treated with platinum-based chemotherapy.Cancer Biol Ther 2010; 10:854–859.
      
      
      
      53.Wu C, Xu B, Yuan P, Miao X, Liu Y, Guan Y, Yu D, Xu J, Zhang T, Shen H, Wu T, Lin D*. Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients. Cancer Res 2010; 70:9721–9729.
      
      
      
      54.Guo Y, Zhang X, Yang M, Miao X, Shi Y, Yao J, Tan W, Sun T, Zhao D, Yu D, Liu J, Lin D*. Functional evaluation of missense variations in the human MAD1L1MAD2L1 genestheir impact on susceptibility to lung cancer.J Med Genet 2010; 47:616–622.
      
      
      
      55.Zhang L, Yang M, Bi N, Ji W, Wu C, Tan W, Zhao L, Yu D, Lin D*, Wang L*. Association of TGF-β1XPD polymorphisms with severe acute radiation-induced esophageal toxicity in locally advanced lung cancer patients treated with radiotherapy. Radiother Oncol 2010; 97:19–25.
      
      
      
      56.Hsiung CA, Lan Q*, Hong YC, Chen CJ, Hosgood HD, Chang IS, Chatterjee N, Brennan P, Wu C, Zheng W, Chang GC, Wu T, Park JY, Hsiao CF, Kim YH, Shen H, Seow A, Yeager M, Tsai YH, Kim YT, Chow WH, Guo H, Wang WC, Sung SW, Hu Z, Chen KY, Kim JH, Chen Y, Huang L, Lee KM, Lo YL, Gao YT, Kim JH, Liu L, Huang MS, Jung TH, Jin G, Caporaso N, Yu D, Kim CH, Su WC, Shu XO, Xu P, Kim IS, Chen YM, Ma H, Shen M, Cha SI, Tan W, Chang CH, Sung JS, Zhang M, Yang TY, Park KH, Yuenger J, Wang CL, Ryu JS, Xiang Y, Deng Q, Hutchinson A, Kim JS, Cai Q, Landi MT, Yu CJ, Park JY, Tucker M, Hung JY, Lin CC, Perng RP, Boffetta P, Chen CY, Chen KC, Yang SY, Hu CY, Chang CK, Fraumeni JF Jr, Chanock S, Yang PC, Rothman N, Lin D. The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet 2010; 6(8):e1001051.
      
      
      
      57.Zhang H, Zhai Y, Hu Z, Wu C, Qian J, Jia W, Ma F, Huang W, Yu L, Yue W, Wang Z, Li P, Zhang Y, Liang R, Wei Z, Cui Y, Xie W, Cai M, Yu X, Yuan Y, Xia X, Zhang X, Yang H, Qiu W, Yang J, Gong F, Chen M, Shen H, Lin D, Zeng Y, He F*, Zhou G*. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 2010; 42;755–758.
      
      
      
      58.Xiong F, Wu C, Bi X, Yu D, Huang L, Xu J, Zhang T, Zhai K, Chang J, Tan W, Cai J*, Lin D*. Risk of genome-wide association study-identified genetic variants for colorectal cancer in a Chinese population.Cancer Epidemiol Biomarkers Prev 2010; 19:1855–1861.
      
      
      
      59.Wu C, Xu B, Yuan B, Ott J, Guan Y, Liu Y, Liu Z, Shen Y, Yu D, Lin D*. Genome-wide examination of genetic variants associated with response to platinum-based chemotherapy in patients with small-cell lung cancer.Pharmacogenet Genomics 2010; 20:389–395.
      
      
      
      60.Zhang L, Yang M, Bi N, Fang M, Sun T, Ji W, Tan W, Zhao L, Yu D, Lin D*, Wang L*. ATM polymorphisms are associated with risk of radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys 2010; 77:1360–1368.
      
      
      
      61.Xiong J, Yu D, Wei N, Fu H, Cai T, Huang Y, Wu Chen, Zheng X, Du Q, Lin D*, Liang Z*. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha positive human breast cencer cell linesclinical samples. FEBS J 2010; 277:1684–1694.
      
      
      
      62.Bi N, Yang M, Zhang L, Chen X, Ji W, Ou G, Lin D*, Wang L*. Cyclooxygenase-2 genetic variants are associated with survival in unrsectable locally advanced non-small-cell lung cancer. Clin Cancer Res 2010; 16:2383–2390.
      
      
      
      63.Tai J, Yang M, Ni, Yu D, Fang J, Tan W, Huang Z, Wu C, Chen X, Wang, Zhou W, Chen X, Zhang W, Ma L, Lin D*, Han D*. Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynxhypopharynx in a Chinese population. Cancer Genet Cytogenet 2010; 196:76–82.
      
      
      
      64.Zhang W, Chen X, Luo A, Lin D, Tan W*, Liu Z*. Genetic variants of C1orf10risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Sci 2009; 100:1695–1700.
      
      
      
      65.Wu C, Wang G, Huang L, Yu D, Tan W, Lin D*. Two genetic variants in prostate stem cell antigengastric cancer susceptibility in a Chinese population.Mol Carcinogen 2009; 48:1131–1138.
      
      
      
      66.Zhao D, Zhang X, Guo Y, Tan W, Lin D*. Cyclooxygenase-2 Gly587Arg variant is associated with differential enzymatic activityrisk of esophageal squamous-cell carcinoma. Mol Carcinogen 2009; 48:934–941.
      
      
      
      67.Yang M, Guo H, Wu C, He Y, Yu D, Zhou L, Wang F, Xu J, Tan W, Wang G, Shen B, Yuan J, Wu T, Lin D*. Functional FEN1 polymorphisms are associated with DNA damage levelslung cancer risk. Hum Mutat 2009; 30:1320–1328.
      
      
      
      68.Ma F, Sun T, Shi Y, Yu D, Tan W, Yang M, Wu C, Chu D, Sun Y, Xu B*, Lin D*. Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib.Lung Cancer 2009; 66:114–119.
      
      
      
      69.Sun T, Hu Z, Shen H, Lin D*. Genetic polymorphisms in cytotoxic T-lymphocyte antigen 4cancer: the dialectical nature of subtle human immune dysregulation. Cancer Res 2009; 69:6011–6014.
      
      
      
      70.Wang G, Yu D, Tan W, Zhao D, Wu C, Lin D*. Genetic polymorphism in chemokine CCL22susceptibility to Helicobacter pylori infection-related gastric carcinoma.Cancer 2009; 115:2430–2437.
      
      
      
      71.Wu C, Hu Z, Yu D, Huang L, Jin G, Liang J, Guo H, Tan W, Zhang M, Qian J, Lu D, Wu T, Lin D*, Shen H*. Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations. Cancer Res 2009; 69:5065–5072.
      
      
      
      72.Zhao D, Xu D, Zhang X, Wang L, Tan W, Guo Y, Yu D, Li H, Zhao P*, Lin D*. Interaction of cyclooxygenase-2 variantssmoking in pancreatic cancer: A possible role of nucleophosmin. Gastroenterology 2009; 136:1659–1668.
      
      
      
      73.Chen H, Yu D, Luo A, Tan W, Zhang C, Zhao D, Yang M, Liu J, Lin D*, Liu Z*. Functional role of S100A14 genetic variantstheir association with esophageal squamous cell carcinoma. Cancer Res 2009; 69:3451–3457.
      
      
      
      74.Singh P, Yang M, Dai H, Yu D, Huang Q, Tan W, Kernstine KH, Lin D*, Shen B*. Overexpressionhypomethylation of Flap endonuclease 1 gene in breastother cancers. Mol Cancer Res 2008; 6:1710–1717.
      
      
      
      75.Sun T, Zhou Y, Yang M, Hu Z, Tan W, Han X, Shi Y, Yao J, Guo Y, Yu D, Tian T, Zhou X, Shen H*, Lin D*. Functional genetic variations in cytotoxic T-lymphocyte antigen 4susceptibility to multiple types of cancer. Cancer Res 2008; 68:7025–7034.
      
      
      
      76.Wang Z*, Xu B, Lin D, Tan W, Jeaw S, Hong X, Hu X. XRCC1 polymorphismssevere toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population. Lung Cancer 2008; 62:99–104.
      
      
      
      77.Wang H, Liu Y, Tan W, Zhang Y, Zhao N, Jiang Y, Lin C, Hao B, Zhao D, Qian J, Lu D, Jin L, Wei Q, Lin D*, He F*. Association of the variable number of tandem repeats polymorphism in the promoter region of the SMYD3 gene with risk of esophageal squamous cell carcinoma in relation to tobacco smoking. Cancer Sci 2008; 99:787–791.
      
      
      
      78.Yang M, Sun T, Wang L, Yu D, Zhang X, Miao X, Liu J, Zhao D, Li H, Tan W, Lin D*. Functional variants in cell death pathway genesrisk of pancreatic cancer. Clin Cancer Res 2008; 14:3230–3236.
      
      
      
      79.Yu D, Zhang X, Liu J, Yuan P, Tan W, Guo Y, Sun T, Zhao D, Ming Y, Liu J, Xu B*, Lin D*. Characterization of functional excision repair cross-complementation group 1 variantstheir association with lung cancer riskprognosis. Clin Cancer Res 2008; 14:2878–2886.
      
      
      
      80.Hu D, Sun T, Ren W, Zheng H, Liu H, Duan Z, Li L, Tan W, Zhao D, Liu Y, Lin D*, Cao Y*. The polymorphisms on Igκ gene are related to susceptibility of breast cancergastric cancer. Genet Test 2008; 12:575–580.
      
      
      
      81.Boccia S, Hung R, Ricciardi G, Gianfagna F, Ebert MP, Fang J, Gao C, Gotze T, Graziano F, Lacasana-Navarro M, Lin D, Lopez-Carrillo L, Qiao Y, Shen H, Stolzenberg-Solomon R, Takezaki T, Weng Y, Zhang F, van Duijn CM, Boffetta P, Taioli E*. Meta-pooled analyses of the methylenetetrahydrofolate reductase C677TA1298C polymorphismsgastric cancer risk: a Huge-GSEC review. Am J Epidemiol 2008; 167:505–516.
      
      
      
      82.Lin Z, Zhang X, Tu J, Guo Y, Green B, Chan C, Tan W, Huang Y, Ling W, Kadlubar FF, Lin D*, Ning B*. A variant of the Cokyne syndrome B gene ERCC6 confers risk of lung cancer. Hum Mutat 2008; 29:113–122.
      
      
      
      83.Lin D*, Li H, Tan W, Miao X, Wang L. Genetic polymorphisms in folate-metabolizing enzymesrisk of gastroesophageal cancers: a potential nutrient-gene interaction in cancer development. Forum Nutr 2007; 60:140–145.
      
      
      
      84.Yang M, Guo Y, Zhang X, Miao X, Tan W, Sun T, Zhao D, Liu J, Lin D*. Interaction of P53 Arg72ProMDM2 T309G polymorphismstheir associations with risk of gastric cardia cancer. Carcinogenesis 2007; 28:1996–2001.
      
      
      
      85.Li Z, Dai H, Zhou M, Li M, Singh P, Qiu J, Tsark W, Huang Q, Kernstine K, Zhang X, Lin D, Shen B*. Fen1 mutations result in autoimmunity, chronic inflammationcancers. Nat Med 2007; 13:812–819.
      
      
      
      86.Sun T, Gao Y, Tan W, Ma S, Shi Y, Yao J, Guo Y, Yang M, Zhang X, Zhang Q, Zeng C*, Lin D*. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet 2007; 39:605–613.
      
      
      
      87.Tan W, Wu J, Zhang X, Guo Y, Liu J, Sun T, Zhang B, Zhao D, Yang M, Yu D, Lin D*. Associations of functional polymorphisms in cyclooxygenase-2platelet 12-lipoxygenase with risk of occurrenceadvanced disease status of colorectal cancer. Carcinogenesis 2007; 28:1197–1201.
      
      
      
      88.Zhao D, Sun T, Zhang X, Guo Y, Yu D, Yang M, Tan W, Wang G, Lin D*. Role of CD14 promoter polymorphisms in Helicobacter pylori infection related gastric carcinoma. Clin Cancer Res 2007; 13:2362–2368.
      
      
      
      89.Zhang B, Sun T, Xue L, Han X, Zhang B, Lu N, Shi Y, Tan W, Zhou Y, Zhao D, Zhang X, Guo Y, Lin D*. Functional polymorphisms in FASFASL contribute to increased apoptosis of tumor infiltration lymphocytesrisk of breast cancer.Carcinogenesis 2007; 28:1067–1073.
      
      
      
      90.Guo Y, Zhang X, Tan W, Miao X, Sun T, Zhao D, Lin D*. Platelet 12-lipoxygenase Arg261Gln polymorphism: Functional characterizationassociation with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.Pharmacogenet Genomics 2007; 17:197–205.
      
      
      
      91.Sun T, Gao Y, Tan W, Ma S, Zhang X, Wang Y, Zhang Q, Guo Y, Zhao D, Zeng C*, Lin D*. Haplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer developmentprogression. Clin Cancer Res 2006; 12:7009–7017.
      
      
      
      92.Wang H, Hao B, Chen X, Zhao N, Cheng G, Jiang Y, Liu Y, Lin C, Tan W, Lu D, Wei Q, Jin L, Lin D*, He F*. Beta-2 adrenergic receptor gene (ADRB2) polymorphismrisk for lung adenocarcinoma: A case-control study in a Chinese population. Cancer Lett 2006; 240:297–305.
      
      
      
      93.Miao X, Zhang X, Zhang L, Guo Y, Hao B, Tan W, He F*, Lin D*. Adenosine diphosphate ribosyl transferaseX-ray repair cross-complementing 1 polymorphisms in gastric cardia cancer. Gastroenterology 2006; 131:420–427.
      
      
      
      94.Cao Y, Miao X, Huang M, Deng L, Hu L, Ernberg I, Zeng Y, Lin D*, Shao J*. Polymorphisms of XRCC1 genesrisk of nasopharyngeal carcinoma in the Cantonese population. BMC Cancer 2006; 6:167.
      
      
      
      95.Hao B, Miao X, Li Y, Zhang X, Sun T, Liang G, Zhao Y, Zhou Y, Wang H, Chen X, Zhang L, Tan W, Wei Q, Lin D*, He F*. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activityincreased risk of non-small cell lung cancer. Oncogene 2006; 25:3613–3620.
      
      
      
      96.Liu F, Pan K, Zhang X, Zhang Y, Zhang L, Ma J, Dong C, Shen L, Li J, Deng D, Lin D, You W*. Genetic variations in cyclooxygenase-2: Expressionrisk of gastric cancerits precursors in a Chinese population. Gastroenterology 2006; 130:1975–1984.
      
      
      
      97.Zhang X, Miao X, Guo Y, Xu N, Hong Y, Liu Z, Tan W, Lin D*. Genetic polymorphisms in cell cycle regulatory genes MDM2P53 are associated with susceptibility to lung cancer risk. Hum Mutat 2006; 27:110–117.
      
      
      
      98.Li Y, Zhang X, Huang G, Miao X, Guo L, Lin D, Lu S*. Identification of a novel polymorphism Arg290Gln of esophageal cancer related gene 1 (ECRG1)it related risk to esophageal squamous cell carcinoma. Carcinogenesis 2006; 27:798–802.
      
      
      
      99.Wang H, Jiang Y, Liu Y, Lin C, Cheng G, Chen X, Hao B, Tan W, Lin D*, He F*. CYP2J2*7 single nucleotide polymorphism in a Chinese population. Clin Chim Acta 2006; 365:125–128.
      
      
      
      100.Verkerk AO, Wilders R, Schulze-Bahr E, Beekman L, Bhuiyan ZA, Bertrand J, Eckardt L, Lin D, Borggrefe M, Breithardt G, Mannens MM, Tan H, Wilde AA, Bezzina CR*. Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome. Cardiovasc Res 2005; 68:441–453.
      
      
      
      101.Sun T, Zhou Y, Li H, Han X, Shi Y, Wang L, Miao X, Tan W, Zhao D, Zhang X, Guo Y, Lin D*. FASL-844C polymorphism is associated with increased activation induced T-cell deathrisk of cervical cancer. J Exp Med 2005; 202:967–974.
      
      
      
      102.Hong Y, Miao X, Zhang X, Guo Y, Tan W, Liu Z*, Lin D*. The role of P53MDM2 polymorphisms in risk of esophageal squamous cell carcinoma. Cancer Res 2005;65:9582–9587.
      
      
      
      103.Zhang X, Miao X, Tan W, Ning B, Liu Z, Hong Y, Song W, Guo Y, Zhang X, Shen Y, Qiang B, Kadlubar FF, Lin D*. Identification of functional genetic variants in cyclooxygenase-2their association with risk of esophageal cancer. Gastroenterology 2005; 129:565–576.
      
      
      
      104.Ning B, Nowell S,"
        ["adept"]=>
        string(0) ""
        ["duodian_doctor_id"]=>
        string(6) "114448"
        ["source_from"]=>
        string(12) "醫(yī)院官網(wǎng)"
        ["is_jingxuan"]=>
        string(1) "0"
        ["title_num"]=>
        string(0) ""
        ["created"]=>
        string(10) "1754967724"
        ["doctor_title"]=>
        string(9) "研究員"
        ["is_seniority"]=>
        int(1)
        ["province_id"]=>
        int(0)
        ["city_id"]=>
        int(0)
        ["hospital_sort"]=>
        string(2) "26"
        ["hospital"]=>
        array(1) {
          [0]=>
          array(29) {
            ["id"]=>
            string(3) "117"
            ["name"]=>
            string(33) "中國醫(yī)學(xué)科學(xué)院腫瘤醫(yī)院"
            ["grade_id"]=>
            string(1) "2"
            ["grade"]=>
            string(6) "三甲"
            ["type"]=>
            string(1) "6"
            ["duodian_hospital_id"]=>
            string(3) "162"
            ["address"]=>
            string(38) "北京市朝陽區(qū)潘家園南里17號"
            ["is_gongli"]=>
            string(1) "1"
            ["logo"]=>
            string(72) "http://pic.39yst.com/group2/M00/89/7A/Co2PPWGoadSAAx0jAAAsIYa1KDo600.png"
            ["is_pay"]=>
            string(1) "0"
            ["pic"]=>
            string(73) "https://pic.39yst.com/group1/M00/3C/51/Pb832lsgfUWAX9HFAAOCyGe8oIM718.jpg"
            ["is_top100"]=>
            string(1) "1"
            ["parent_areaid"]=>
            string(1) "1"
            ["areaid"]=>
            string(2) "72"
            ["top100_sort"]=>
            string(2) "26"
            ["guide"]=>
            string(0) ""
            ["tel"]=>
            string(12) "010-67781331"
            ["is_seniority"]=>
            string(1) "1"
            ["hospital_title"]=>
            string(6) "三甲"
            ["hospital_grade_id"]=>
            string(1) "2"
            ["hospital_type"]=>
            string(12) "腫瘤醫(yī)院"
            ["hospital_type_id"]=>
            string(1) "6"
            ["hospital"]=>
            string(33) "中國醫(yī)學(xué)科學(xué)院腫瘤醫(yī)院"
            ["department_id"]=>
            string(1) "0"
            ["duodian_department_id"]=>
            string(6) "211339"
            ["duodian_department_pid"]=>
            string(6) "211329"
            ["department_name"]=>
            string(0) ""
            ["hospital_department"]=>
            string(24) "病因及癌變研究室"
            ["duty"]=>
            array(0) {
            }
          }
        }
        ["version"]=>
        int(40)
        ["isHaveSource"]=>
        int(0)
        ["duty"]=>
        string(0) ""
      }
      
      首頁中國醫(yī)學(xué)科學(xué)院腫瘤醫(yī)院林東昕
      林東昕
      林東昕研究員
      簡介: 展開
      中國醫(yī)學(xué)科學(xué)院腫瘤醫(yī)院
      中國醫(yī)學(xué)科學(xué)院腫瘤醫(yī)院
      病因及癌變研究室
      三甲 腫瘤醫(yī)院
      第一執(zhí)業(yè)
      本醫(yī)院號源已約滿,可選擇該醫(yī)生其他出診地
      江蘇民??悼萍脊煞萦邢薰咀詤f(xié)議
      一、總則

      1.1江蘇民??悼萍脊煞萦邢薰镜乃袡?quán)和運(yùn)營權(quán)歸江蘇民??悼萍脊煞萦邢薰舅小?/p>

      1.2 用戶在注冊之前,應(yīng)當(dāng)仔細(xì)閱讀本協(xié)議,并同意遵守本協(xié)議后方可成為注冊用戶。一旦注冊成功,則用戶與江蘇民??悼萍脊煞萦邢薰局g自動形成協(xié)議關(guān)系,用戶應(yīng)當(dāng)受本協(xié)議的約束。用戶在使用特殊的服務(wù)或產(chǎn)品時,應(yīng)當(dāng)同意接受相關(guān)協(xié)議后方能使用。

      1.3 本協(xié)議則可由江蘇民??悼萍脊煞萦邢薰倦S時更新,用戶應(yīng)當(dāng)及時關(guān)注并同意本站不承擔(dān)通知義務(wù)。本站的通知、公告、聲明或其它類似內(nèi)容是本協(xié)議的一部分。

      二、服務(wù)內(nèi)容

      2.1江蘇民福康科技股份有限公司的具體內(nèi)容由本站根據(jù)實(shí)際情況提供。

      2.2 本站僅提供相關(guān)的網(wǎng)絡(luò)服務(wù),除此之外與相關(guān)網(wǎng)絡(luò)服務(wù)有關(guān)的設(shè)備(如個人電腦、手機(jī)、及其他與接入互聯(lián)網(wǎng)或移動網(wǎng)有關(guān)的裝置)及所需的費(fèi)用(如為接入互聯(lián)網(wǎng)而支付的電話費(fèi)及上網(wǎng)費(fèi)、為使用移動網(wǎng)而支付的手機(jī)費(fèi))均應(yīng)由用戶自行負(fù)擔(dān)。

      三、用戶帳號

      3.1經(jīng)本站注冊系統(tǒng)完成注冊程序并通過身份認(rèn)證的用戶即成為正式用戶,可以獲得本站規(guī)定用戶所應(yīng)享有的一切權(quán)限;未經(jīng)認(rèn)證僅享有本站規(guī)定的部分會員權(quán)限。江蘇民??悼萍脊煞萦邢薰居袡?quán)對會員的權(quán)限設(shè)計進(jìn)行變更。

      3.2 用戶只能按照注冊要求使用真實(shí)姓名,及身份證號注冊。用戶有義務(wù)保證密碼和帳號的安全,用戶利用該密碼和帳號所進(jìn)行的一切活動引起的任何損失或損害,由用戶自行承擔(dān)全部責(zé)任,本站不承擔(dān)任何責(zé)任。如用戶發(fā)現(xiàn)帳號遭到未授權(quán)的使用或發(fā)生其他任何安全問題,應(yīng)立即修改帳號密碼并妥善保管,如有必要,請通知本站。因黑客行為或用戶的保管疏忽導(dǎo)致帳號非法使用,本站不承擔(dān)任何責(zé)任。

      四、使用規(guī)則

      4.1遵守中華人民共和國相關(guān)法律法規(guī),包括但不限于《中華人民共和國計算機(jī)信息系統(tǒng)安全保護(hù)條例》、《計算機(jī)軟件保護(hù)條例》、《高人民法院關(guān)于審理涉及計算機(jī)網(wǎng)絡(luò)著作權(quán)糾紛案件適用法律若干問題的解釋(法釋[2004]1號)》、《全國人大常委會關(guān)于維護(hù)互聯(lián)網(wǎng)安全的決定》、《互聯(lián)網(wǎng)電子公告服務(wù)管理規(guī)定》、《互聯(lián)網(wǎng)新聞信息服務(wù)管理規(guī)定》、《互聯(lián)網(wǎng)著作權(quán)行政保護(hù)辦法》和《信息網(wǎng)絡(luò)傳播權(quán)保護(hù)條例》等有關(guān)計算機(jī)互聯(lián)網(wǎng)規(guī)定和知識產(chǎn)權(quán)的法律和法規(guī)、實(shí)施辦法。

      4.2 用戶對其自行發(fā)表、上傳或傳送的內(nèi)容負(fù)全部責(zé)任,所有用戶不得在本站任何頁面發(fā)布、轉(zhuǎn)載、傳送含有下列內(nèi)容之一的信息,否則本站有權(quán)自行處理并不通知用戶:

      (1)違反憲法確定的基本原則的;

      (2)危害國家安全,泄漏國家機(jī)密,顛覆國家政權(quán),破壞國家統(tǒng)一的;

      (3)損害國家榮譽(yù)和利益的;

      (4)煽動民族仇恨、民族歧視,破壞民族團(tuán)結(jié)的;

      (5)破壞國家宗教政策,宣揚(yáng)邪教和封建迷信的;

      (6)散布謠言,擾亂社會秩序,破壞社會穩(wěn)定的;

      (7)散布淫穢、色情、賭博、暴力、恐怖或者教唆犯罪的;

      (8)侮辱或者誹謗他人,侵害他人合法權(quán)益的;

      (9)煽動非法集會、結(jié)社、游行、示威、聚眾擾亂社會秩序的;

      (10)以非法民間組織名義活動的;

      (11)含有法律、行政法規(guī)禁止的其他內(nèi)容的。

      4.3用戶承諾對其發(fā)表或者上傳于本站的所有信息(即屬于《中華人民共和國著作權(quán)法》規(guī)定的作品,包括但不限于文字、圖片、音樂、電影、表演和錄音錄像制品和電腦程序等)均享有完整的知識產(chǎn)權(quán),或者已經(jīng)得到相關(guān)權(quán)利人的合法授權(quán);如用戶違反本條規(guī)定造成本站被第三人索賠的,用戶應(yīng)全額補(bǔ)償本站一切費(fèi)用(包括但不限于各種賠償費(fèi)、訴訟代理費(fèi)及為此支出的其它合理費(fèi)用);

      4.4 當(dāng)?shù)谌秸J(rèn)為用戶發(fā)表或者上傳于本站的信息侵犯其權(quán)利,并根據(jù)《信息網(wǎng)絡(luò)傳播權(quán)保護(hù)條例》或者相關(guān)法律規(guī)定向本站發(fā)送權(quán)利通知書時,用戶同意本站可以自行判斷決定刪除涉嫌侵權(quán)信息,除非用戶提交書面證據(jù)材料排除侵權(quán)的可能性,本站將不會自動恢復(fù)上述刪除的信息;

      (1)不得為任何非法目的而使用網(wǎng)絡(luò)服務(wù)系統(tǒng);

      (2)遵守所有與網(wǎng)絡(luò)服務(wù)有關(guān)的網(wǎng)絡(luò)協(xié)議、規(guī)定和程序;

      (3)不得利用本站進(jìn)行任何可能對互聯(lián)網(wǎng)的正常運(yùn)轉(zhuǎn)造成不利影響的行為;

      (4)不得利用本站進(jìn)行任何不利于本站的行為。

      4.5如用戶在使用網(wǎng)絡(luò)服務(wù)時違反上述任何規(guī)定,本站有權(quán)要求用戶改正或直接采取一切必要的措施(包括但不限于刪除用戶張貼的內(nèi)容、暫?;蚪K止用戶使用網(wǎng)絡(luò)服務(wù)的權(quán)利)以減輕用戶不當(dāng)行為而造成的影響。

      五、隱私保護(hù)

      5.1本站不對外公開或向第三方提供單個用戶的注冊資料及用戶在使用網(wǎng)絡(luò)服務(wù)時存儲在本站的非公開內(nèi)容,但下列情況除外:

      (1)事先獲得用戶的明確授權(quán);

      (2)根據(jù)有關(guān)的法律法規(guī)要求;

      (3)按照相關(guān)政府主管部門的要求;

      (4)為維護(hù)社會公眾的利益。

      5.2本站可能會與第三方合作向用戶提供相關(guān)的網(wǎng)絡(luò)服務(wù),在此情況下,如該第三方同意承擔(dān)與本站同等的保護(hù)用戶隱私的責(zé)任,則本站有權(quán)將用戶的注冊資料等提供給該第三方。

      5.3 在不透露單個用戶隱私資料的前提下,本站有權(quán)對整個用戶數(shù)據(jù)庫進(jìn)行分析并對用戶數(shù)據(jù)庫進(jìn)行商業(yè)上的利用。

      六、版權(quán)聲明

      6.1本站的文字、圖片、音頻、視頻等版權(quán)均歸江蘇民??悼萍脊煞萦邢薰鞠碛谢蚺c作者共同享有,未經(jīng)本站許可,不得任意轉(zhuǎn)載。

      6.2 本站特有的標(biāo)識、版面設(shè)計、編排方式等版權(quán)均屬江蘇民??悼萍脊煞萦邢薰鞠碛?,未經(jīng)本站許可,不得任意復(fù)制或轉(zhuǎn)載。

      6.3 使用本站的任何內(nèi)容均應(yīng)注明“來源于江蘇民??悼萍脊煞萦邢薰尽奔笆鹕献髡咝彰?,按法律規(guī)定需要支付稿酬的,應(yīng)當(dāng)通知本站及作者及支付稿酬,并獨(dú)立承擔(dān)一切法律責(zé)任。

      6.4由于本站付有作者相應(yīng)稿酬,凡在后臺生成的有效文章不可刪除,版權(quán)歸江蘇民??悼萍脊煞萦邢薰舅小?/p>

      6.5 本站所有內(nèi)容僅代表作者自己的立場和觀點(diǎn),與本站無關(guān),由作者本人承擔(dān)一切法律責(zé)任。

      6.6 惡意轉(zhuǎn)載本站內(nèi)容的,本站保留將其訴諸法律的權(quán)利。

      七、責(zé)任聲明

      7.1用戶明確同意其使用本站網(wǎng)絡(luò)服務(wù)所存在的風(fēng)險及一切后果將完全由用戶本人承擔(dān),江蘇民??悼萍脊煞萦邢薰緦Υ瞬怀袚?dān)任何責(zé)任。

      7.2 本站無法保證網(wǎng)絡(luò)服務(wù)一定能滿足用戶的要求,也不保證網(wǎng)絡(luò)服務(wù)的及時性、安全性、準(zhǔn)確性。

      7.3 本站不保證為方便用戶而設(shè)置的外部鏈接的準(zhǔn)確性和完整性,同時,對于該等外部鏈接指向的不由本站實(shí)際控制的任何網(wǎng)頁上的內(nèi)容,本站不承擔(dān)任何責(zé)任。

      7.4 對于因不可抗力或本站不能控制的原因造成的網(wǎng)絡(luò)服務(wù)中斷或其它缺陷,本站不承擔(dān)任何責(zé)任,但將盡力減少因此而給用戶造成的損失和影響。

      7.5 對于站向用戶提供的下列產(chǎn)品或者服務(wù)的質(zhì)量缺陷本身及其引發(fā)的任何損失,本站無需承擔(dān)任何責(zé)任:

      (1)本站向用戶免費(fèi)提供的各項(xiàng)網(wǎng)絡(luò)服務(wù);

      (2)本站向用戶贈送的任何產(chǎn)品或者服務(wù)。

      7.6本站有權(quán)于任何時間暫時或永久修改或終止本服務(wù)(或其任何部分),而無論其通知與否,本站對用戶和任何第三人均無需承擔(dān)任何責(zé)任。

      八、附則

      8.1本協(xié)議的訂立、執(zhí)行和解釋及爭議的解決均應(yīng)適用中華人民共和國法律。

      8.2 如本協(xié)議中的任何條款無論因何種原因完全或部分無效或不具有執(zhí)行力,本協(xié)議的其余條款仍應(yīng)有效并且有約束力。

      8.3 本協(xié)議解釋權(quán)及修訂權(quán)歸江蘇民??悼萍脊煞萦邢薰舅小?/p>